HK1246292A1 - 1,3,5-三嗪衍生物及其使用方法 - Google Patents

1,3,5-三嗪衍生物及其使用方法

Info

Publication number
HK1246292A1
HK1246292A1 HK18105822.3A HK18105822A HK1246292A1 HK 1246292 A1 HK1246292 A1 HK 1246292A1 HK 18105822 A HK18105822 A HK 18105822A HK 1246292 A1 HK1246292 A1 HK 1246292A1
Authority
HK
Hong Kong
Prior art keywords
same
triazine derivative
triazine
derivative
Prior art date
Application number
HK18105822.3A
Other languages
English (en)
Inventor
趙娜
王樹龍
劉希傑
胡遠東
張慧
羅鴻
彭勇
韓永信
張喜全
徐宏江
Original Assignee
正大天晴藥業集團股份有限公司
連云港潤衆制藥有限公司
北京賽林泰醫藥技術有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 正大天晴藥業集團股份有限公司, 連云港潤衆制藥有限公司, 北京賽林泰醫藥技術有限公司 filed Critical 正大天晴藥業集團股份有限公司
Publication of HK1246292A1 publication Critical patent/HK1246292A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40Nitrogen atoms
    • C07D251/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK18105822.3A 2015-07-30 2018-05-07 1,3,5-三嗪衍生物及其使用方法 HK1246292A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510459126 2015-07-30
PCT/CN2016/092254 WO2017016513A1 (zh) 2015-07-30 2016-07-29 1,3,5-三嗪衍生物及其使用方法

Publications (1)

Publication Number Publication Date
HK1246292A1 true HK1246292A1 (zh) 2018-09-07

Family

ID=57884121

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18105822.3A HK1246292A1 (zh) 2015-07-30 2018-05-07 1,3,5-三嗪衍生物及其使用方法

Country Status (16)

Country Link
US (1) US10745383B2 (zh)
EP (1) EP3330258B1 (zh)
JP (1) JP6786086B2 (zh)
KR (1) KR102303011B1 (zh)
CN (2) CN113307794A (zh)
AU (1) AU2016299092B2 (zh)
CA (1) CA2993687C (zh)
DK (1) DK3330258T3 (zh)
ES (1) ES2881695T3 (zh)
HK (1) HK1246292A1 (zh)
HU (1) HUE056537T2 (zh)
PT (1) PT3330258T (zh)
RU (1) RU2724333C2 (zh)
TW (1) TWI722004B (zh)
WO (1) WO2017016513A1 (zh)
ZA (1) ZA201801301B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10961222B2 (en) 2016-07-21 2021-03-30 Nanjing Sanhome Pharmaceutical Co., Ltd. Chemical compound of isocitrate dehydrogenase inhibitor, and application thereof
US11021464B2 (en) * 2017-01-22 2021-06-01 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Crystalline forms of 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine methanesulfonic acid salt
CN109265444B (zh) * 2017-07-17 2022-03-11 南京圣和药业股份有限公司 取代的三嗪类idh抑制剂的光学异构体及其应用
CN109467538A (zh) * 2017-09-07 2019-03-15 和记黄埔医药(上海)有限公司 环烯烃取代的杂芳环类化合物及其用途
CN110054615B (zh) * 2018-01-19 2021-06-15 南京圣和药业股份有限公司 三嗪类idh抑制剂甲磺酸盐的晶型
CN110054614B (zh) * 2018-01-19 2021-12-28 南京圣和药业股份有限公司 三嗪类idh抑制剂的可药用盐及其制备方法
CN110054616B (zh) * 2018-01-19 2021-11-23 南京圣和药业股份有限公司 三嗪类idh抑制剂的制备方法
WO2020048449A1 (zh) 2018-09-03 2020-03-12 正大天晴药业集团股份有限公司 包含1,3,5-三嗪衍生物或其盐的固体药物组合物
KR20210124569A (ko) * 2020-04-03 2021-10-15 주식회사 하임바이오 암 치료를 위한 신규 화합물 및 이를 포함하는 조성물
CN116209655A (zh) * 2020-11-09 2023-06-02 贝达药业股份有限公司 突变型idh1和idh2抑制剂及其应用
WO2023134686A1 (zh) * 2022-01-11 2023-07-20 正大天晴药业集团股份有限公司 一种1,3,5-三嗪衍生物的制备方法
WO2023174235A1 (zh) * 2022-03-15 2023-09-21 贝达药业股份有限公司 突变型idh1和idh2抑制剂及其应用
WO2024008138A1 (zh) * 2022-07-07 2024-01-11 正大天晴药业集团股份有限公司 1,3,5-三嗪衍生物的药物组合

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1001665A (en) * 1961-06-05 1965-08-18 American Cyanamid Co Triazine derivatives and process for their preparation
JP3051896B2 (ja) * 1991-03-20 2000-06-12 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
US7919487B2 (en) 2004-11-10 2011-04-05 Synta Pharmaceuticals Corporation Heteroaryl compounds
US20060235098A1 (en) 2005-04-19 2006-10-19 Burdeniuc Juan J Polyurethane foams made with blowing catalyst compositions containing primary hydroxyl groups and high ethylenediamine backbones
US9321735B2 (en) 2010-07-20 2016-04-26 Vestaron Corporation Insecticidal triazines and pyrimidines
CN115536635A (zh) * 2012-01-06 2022-12-30 法国施维雅药厂 治疗活性化合物及其使用方法
WO2015003360A2 (en) * 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
WO2015017821A2 (en) 2013-08-02 2015-02-05 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
US9975878B2 (en) 2013-11-21 2018-05-22 Ptc Therapeutics, Inc. Substituted triazine BMI-1 inhibitors

Also Published As

Publication number Publication date
CN113307794A (zh) 2021-08-27
BR112018001780A2 (zh) 2018-09-11
EP3330258B1 (en) 2021-07-14
ES2881695T3 (es) 2021-11-30
CN107922358A (zh) 2018-04-17
RU2018105614A3 (zh) 2019-11-20
KR102303011B1 (ko) 2021-09-16
AU2016299092A1 (en) 2018-02-22
HUE056537T2 (hu) 2022-02-28
KR20180031036A (ko) 2018-03-27
US20190062308A1 (en) 2019-02-28
RU2018105614A (ru) 2019-08-29
TW201704224A (zh) 2017-02-01
WO2017016513A1 (zh) 2017-02-02
CA2993687A1 (en) 2017-02-02
RU2724333C2 (ru) 2020-06-23
EP3330258A4 (en) 2019-01-02
US10745383B2 (en) 2020-08-18
CN107922358B (zh) 2021-05-07
JP6786086B2 (ja) 2020-11-18
AU2016299092B2 (en) 2020-08-20
CA2993687C (en) 2023-09-26
TWI722004B (zh) 2021-03-21
JP2018521104A (ja) 2018-08-02
ZA201801301B (en) 2020-07-29
PT3330258T (pt) 2021-08-19
DK3330258T3 (da) 2021-08-16
EP3330258A1 (en) 2018-06-06

Similar Documents

Publication Publication Date Title
HK1246292A1 (zh) 1,3,5-三嗪衍生物及其使用方法
HK1249101A1 (zh) 作為magl抑制劑的1,1,1-三氟-3-羥基丙-2-基氨基甲酸酯衍生物及1,1,1-三氟-4-羥基丁-2-基氨基甲酸酯衍生物
IL268988B (en) Solid formations of isoquinolinone derivatives, process for their preparation, compositions containing them and methods of use
HK1254654A1 (zh) 4,6-亞嘧啶基衍生物及其用途
IL289789A (en) Compounds and methods for lowering tau expression
GB2557741B (en) Icariside compound, preperation method thereof, and application thereof
ZA201807364B (en) Benzotriazole derivative, manufacturing method therefor and use thereof
PL3309138T3 (pl) Sposób koprodukcji 2,3,3,3-tetrafluoropropylenu i 1,3,3,3-tetrafluoropropylenu
FI3394259T3 (fi) Koostumuksia ja menetelmiä tau:n ilmentymisen vähentämiseksi
PT3552017T (pt) Compostos úteis como inibidores de ripk1
GB201600142D0 (en) Attachment assembly,parts for same,and method of using same
PT3135110T (pt) Derivados de 1,7-diaril-1,6-heptadieno-3,5-diona, processos para a produção e utilização dos mesmos
GB201503776D0 (en) Compound and method
GB201520255D0 (en) Composition and method
PL3360863T3 (pl) Pochodna i związek pośredni etomidatu, sposób przygotowania i zastosowanie
ZA202002138B (en) Method for preparing oxaspirocycle derivative, and intermediate thereof
GB201700116D0 (en) Method and composition
LT3150790T (lt) Staliaus dirbinių montavimo būdas ir staliaus dirbinių montavimo detalių rinkinys
EP3190910A4 (en) System and method of adjusting the fit of clothing
GB201509420D0 (en) Composition and method
IL265131A (en) Derivation of stilbene and a method for its preparation
GB201715139D0 (en) Security Method
EP3334424A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALOPECIA
GB201513492D0 (en) Method and composition
TWI562978B (en) Method for preparation of 1,4-cyclohexanedialkanol